Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Reversal of Ethanol-induced Intoxication by a Novel Modulator of Gβγ Protein Potentiation of the Glycine Receptor.

San Martin L, Cerda F, Jin C, Jimenez V, Yevenes GE, Hernandez T, Nova D, Fuentealba J, Aguayo LG, Guzman L.

J Biol Chem. 2016 Sep 2;291(36):18791-8. doi: 10.1074/jbc.M116.740555. Epub 2016 Jul 11.

PMID:
27402845
2.

Regulation of retinal angiogenesis by phospholipase C-β3 signaling pathway.

Ha JM, Baek SH, Kim YH, Jin SY, Lee HS, Kim SJ, Shin HK, Lee DH, Song SH, Kim CD, Bae SS.

Exp Mol Med. 2016 Jun 17;48(6):e240. doi: 10.1038/emm.2016.39.

3.

Finding directionality and gene-disease predictions in disease associations.

Garcia-Albornoz M, Nielsen J.

BMC Syst Biol. 2015 Jul 15;9:35. doi: 10.1186/s12918-015-0184-9.

4.

Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Ghanemi A.

Saudi Pharm J. 2015 Apr;23(2):115-29. doi: 10.1016/j.jsps.2013.07.007. Epub 2013 Aug 13. Review.

5.

G-protein βγ subunit dimers modulate kidney repair after ischemia-reperfusion injury in rats.

White SM, North LM, Haines E, Goldberg M, Sullivan LM, Pressly JD, Weber DS, Park F, Regner KR.

Mol Pharmacol. 2014 Oct;86(4):369-77. doi: 10.1124/mol.114.092346. Epub 2014 Jul 15.

6.

Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.

Gaspari S, Papachatzaki MM, Koo JW, Carr FB, Tsimpanouli ME, Stergiou E, Bagot RC, Ferguson D, Mouzon E, Chakravarty S, Deisseroth K, Lobo MK, Zachariou V.

Neuropsychopharmacology. 2014 Jul;39(8):1968-77. doi: 10.1038/npp.2014.45. Epub 2014 Feb 24.

7.

Phosphoinositides: tiny lipids with giant impact on cell regulation.

Balla T.

Physiol Rev. 2013 Jul;93(3):1019-137. doi: 10.1152/physrev.00028.2012. Review.

8.

Neural processing of itch.

Akiyama T, Carstens E.

Neuroscience. 2013 Oct 10;250:697-714. doi: 10.1016/j.neuroscience.2013.07.035. Epub 2013 Jul 24. Review.

9.

Structural insights into phospholipase C-β function.

Lyon AM, Tesmer JJ.

Mol Pharmacol. 2013 Oct;84(4):488-500. doi: 10.1124/mol.113.087403. Epub 2013 Jul 23. Review.

10.

Molecular targeting of Gα and Gβγ subunits: a potential approach for cancer therapeutics.

Smrcka AV.

Trends Pharmacol Sci. 2013 May;34(5):290-8. doi: 10.1016/j.tips.2013.02.006. Epub 2013 Apr 1. Review.

11.

Full-length Gα(q)-phospholipase C-β3 structure reveals interfaces of the C-terminal coiled-coil domain.

Lyon AM, Dutta S, Boguth CA, Skiniotis G, Tesmer JJ.

Nat Struct Mol Biol. 2013 Mar;20(3):355-62. doi: 10.1038/nsmb.2497. Epub 2013 Feb 3.

12.
13.

Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.

Shi TJ, Zhang MD, Zeberg H, Nilsson J, Grünler J, Liu SX, Xiang Q, Persson J, Fried KJ, Catrina SB, Watanabe M, Arhem P, Brismar K, Hökfelt TG.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):690-5. doi: 10.1073/pnas.1220794110. Epub 2012 Dec 24.

14.

Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Harrison LM.

Cell Mol Neurobiol. 2012 Aug;32(6):907-18. doi: 10.1007/s10571-012-9830-6. Epub 2012 Mar 27. Review.

15.

The phospholipase C isozymes and their regulation.

Gresset A, Sondek J, Harden TK.

Subcell Biochem. 2012;58:61-94. doi: 10.1007/978-94-007-3012-0_3. Review.

16.

Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.

Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF.

Cell. 2011 Oct 14;147(2):447-58. doi: 10.1016/j.cell.2011.08.043.

17.

Itch signaling in the nervous system.

Jeffry J, Kim S, Chen ZF.

Physiology (Bethesda). 2011 Aug;26(4):286-92. doi: 10.1152/physiol.00007.2011. Review.

18.

Direct-reversible binding of small molecules to G protein βγ subunits.

Seneviratne AM, Burroughs M, Giralt E, Smrcka AV.

Biochim Biophys Acta. 2011 Sep;1814(9):1210-8. doi: 10.1016/j.bbapap.2011.05.010. Epub 2011 May 18.

19.

A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, Zachariou V.

J Neurosci. 2011 Apr 13;31(15):5617-24. doi: 10.1523/JNEUROSCI.4146-10.2011. Erratum in: J Neurosci. 2011 May 18;31(20):7578. Psigfogeorgou, Kassi [corrected to Psifogeorgou, Kassi].

20.

Mice lacking rhes show altered morphine analgesia, tolerance, and dependence.

Lee FA, Baiamonte BA, Spano D, Lahoste GJ, Soignier RD, Harrison LM.

Neurosci Lett. 2011 Feb 11;489(3):182-6. doi: 10.1016/j.neulet.2010.12.012. Epub 2010 Dec 14.

Supplemental Content

Support Center